Ex-Takeda Exec Settles SEC Insider Trading Claims

Law360, New York (February 9, 2012, 3:07 PM EST) -- A former Takeda Pharmaceuticals International Inc. executive agreed Thursday to pay $136,000 to settle a U.S. Securities and Exchange Commission suit alleging he profited from insider trading before a major Takeda acquisition.

The SEC filed and settled the suit alleging Brent C. Bankosky, a former senior director in Takeda’s U.S. business development group, used nonpublic information to place personal trades before Takeda purchased Millennium Pharmaceuticals Inc. for $8.8 billion in April 2008. Bankosky also traded in advance of a March 2008 strategic alliance between Takeda and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.